Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...

In 2025, nearly 1,100 GKAS events are scheduled to take place throughout the nation, and it is estimated that approximately ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...

The perception of Henry Schein by financial experts ... The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

Shares of Henry Schein were up more than 3% at $78.54 premarket. The medical and dental supplies distributor, which has a market capitalization of about $9.5 billion, has reportedly come under ...

confirming an earlier Wall Street Journal report. Henry Schein has agreed to give the private-equity firm two board seats.

These solutions also support dental laboratories ... with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.